Blood Platelets
9
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Platelets Activation in Brain Neoplasms
Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor
grouP O wholE blooD : storagE leSion impacT And infLammation
Post-Injury Platelet Biology: Mechanisms and Outcomes
Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients
PACT (Platelet Activity After Clopidogrel Termination)
Effects of the Use of Platelet-rich Fibrin on Bone Regeneration After Impacted Third Molar Surgery
Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions
Trial to Reduce Alloimmunization to Platelets (TRAP)